Point-of-Care Testing (POCT) Market Size, Share, Growth Analysis, By Product Type(Covid -19 testing kits, Glucose monitoring products), By Platform(Lateral Flow Assays, Dipsticks), By Mode of Purchase(OTC products, Prescribed based products), By Testing Type(Immunoassays, Cell-Based Assays), By End-User(Clinical laboratories, Ambulatory care facilities and physician offices), By Geography(North America, Europe) - Industry Forecast 2024-2031

Point-of-Care Testing (POCT) Market Competitive Landscape

To understand the competitive landscape, we are analyzing key Point-of-Care Testing (POCT) Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Point-of-Care Testing (POCT) Market.

To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.

Key Players Covered in the Report:

• Sinocare Inc
• Hoffmann La Roche Ltd
• Siemens AG
• Abott Laboratories
• bioMrieux SA
• Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC
• Mankind pharma
• OraSure Technologies, inc
• A. Menarini Diagnostics s.r.l
• ACON Laboratories
• Trinity Biotech plc